About MabPlex
MabPlex is a company based in Yantai (China) founded in 2013. MabPlex has raised $130 million across 2 funding rounds from investors including Orbimed, Sunshine Insurance Group and Detong Capital. MabPlex offers products and services including CDMO Services, Research Development, and GMP Manufacturing. MabPlex operates in a competitive market with competitors including Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and ProBioGen AG, among others.
- Headquarter Yantai, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mabplex International Co. Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$130 M (USD)
in 2 rounds
-
Latest Funding Round
$71 M (USD), Series B
Jun 08, 2020
-
Investors
Orbimed
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MabPlex
MabPlex offers a comprehensive portfolio of products and services, including CDMO Services, Research Development, and GMP Manufacturing.
Offers contract services for biologics research and production
Provides development support for biopharmaceutical innovations
Delivers compliant manufacturing for biologics and ADCs
Funding Insights of MabPlex
MabPlex has successfully raised a total of $130M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $71 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MabPlex
MabPlex has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed, Sunshine Insurance Group and Detong Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for MabPlex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MabPlex
Investment portfolio details for MabPlex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MabPlex
Detailed financials for MabPlex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mabplex Comparisons
Peer comparison for MabPlex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MabPlex
MabPlex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and ProBioGen AG, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mammalian cell culture biologics are developed through contract research services.
|
|
| Locked | Locked | Locked |
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
|
|
| Locked | Locked | Locked |
Contract manufacturing solutions for biologics are provided to Asian companies.
|
|
| Locked | Locked | Locked |
Drug substance development, analytical, and compliance services are provided.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars
|
Detailed competitors of MabPlex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mabplex
Complete news archive for MabPlex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MabPlex
MabPlex was founded in 2013 and raised its 1st funding round 6 years after it was founded.
MabPlex is headquartered in Yantai, China. It is registered at Yantai, Shandong, China.
MabPlex is a funded company, having raised a total of $130M across 2 funding rounds to date.
MabPlex was established in 2013 as a contract development and manufacturing organization based in Yantai, China. Focus is placed on biologics, including antibody-drug conjugates, mammalian cell-line derived active pharmaceutical ingredients, and monoclonal antibodies. Services encompass cell banking, protein characterization, formulation, lyophilization, fill-finish operations, and final packaging. Quality assurance, control, and regulatory support are provided, with compliance to FDA, EMA, and CFDA standards maintained.
MabPlex's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
MabPlex offers CDMO Services, Research Development, and GMP Manufacturing.
MabPlex has 10 investors. Key investors include Orbimed, Sunshine Insurance Group, Detong Capital, CMS China, and Huayao Capital.